Lupin launches generic drug in the US market

The Mumbai-based drug firm's product is the generic equivalent of Zyla Life Sciences' Vivlodex Capsules (5 mg and 10 mg). The capsules are indicated for management of osteoarthritis (OA) pain.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rA3Lht
via IFTTT